Tocilizumab in Chronic Inflammatory CPPD Disease

NCT07254637 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Calcium Pyrophosphate Deposition Disease

Interventions

DRUG: Tocilizumab
OTHER: Placebo

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]